ArticleDrug design, development and therapy2022

Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.

Tarfah Al-Warhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.